Author |
Title |
JournalName |
Year D |
Click on Column Headers to Re-Sort The Current List |
Burroughs W |
Letter From A Master Addict To Dangerous Drugs |
British Journal of A... |
1956 |
Cerletti A |
Teonanacatl und Psilocybin |
Deutsche Medizinishe... |
1959 |
Cohen S |
The therapeutic potential of LSD-25 |
A Pharmacologic Appr... |
1959 |
Hofmann A, Heim R, Brack ... |
Psilocybin und Psilocin, zwei psychotrope Wirkstoffe aus mexikanischen... |
Helv. chim. Acta |
1959 |
Associated Press |
Kids Shooting Peanut Butter |
San Francisco Chroni... |
1969 |
Fisher G, Martin AJ |
The Psychotherapeutic Use Of Psychodysleptic Drugs |
Voices: The Art and ... |
1970 |
Winkelhake JL, Voss W Jr,... |
Comparative Inhibitory Action of D- and L-Tryptophan on the Effect of ... |
Molec Pharmacol. |
1974 |
Reichelt J |
Analytical Studies Of Ergot Alkaloids And Their Derivatives. IV. Quick... |
Cs. Farm. |
1976 |
Schild HO |
L'ergot de seigle: des conceptions de dale aux récepteurs |
J.Pharmacol. |
1979 |
[No authors listed] |
The 1977 Street Drug Analysis results: PharmChem Research Foundation |
Clin Toxicol |
1979 |
Shulgin AT |
The background and chemistry of MDMA |
J Psychoactive Drugs |
1986 |
Koreeda M, Brown L, Vald |
The Absolute Stereochemistry of Salvinorins |
The Chemical Society... |
1990 |
Glennon RA |
Phenylalkylamine stimulants, hallucinogens, and designer drugs |
NIDA Res Monogr |
1991 |
Tsarong TJ |
Tibetan Psychopharmacology |
Integration |
1991 |
Riedlinger, FLS TJ |
Existential Transactions at Harvard: Timothy Leary's Humanistic Psycho... |
Journal of Humanisti... |
1993 |
Westkaemper RB, Glennon R... |
Molecular Modeling of the Interaction of LSD and Other Hallucinogens W... |
NIDA Research Monogr... |
1994 |
Young R, Dukat M, Malmusi... |
Stimulus properties of PMMA: effect of optical isomers and conformatio... |
Pharmacol Biochem Be... |
1999 |
Glennon RA |
Arylalkylamine drugs of abuse: an overview of drug discrimination stud... |
Pharmacol Biochem Be... |
1999 |
Rothman RB, Partilla JS, ... |
Neurochemical neutralization of methamphetamine with high-affinity non... |
Synapse |
2000 |
Smith KM, Larive LL, Roma... |
Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hyd... |
Am J Health Syst Pha... |
2002 |
De Feo V. |
Ethnomedical Field Study in Northern Peruvian Andes with Particular Re... |
Journal of Ethnophar... |
2003 |
Liu D, Chen XY, Zhang YF,... |
[Determination of dextrorphan in human plasma and pharmacokinetic stud... |
Yao Xue Xue Bao |
2004 |
Pizarro N, Farre M, Pujad... |
Stereochemical analysis of 3,4-methylenedioxymethamphetamine and its m... |
Drug Metab Dispos |
2004 |
Boyer EW |
Dextromethorphan abuse |
Pediatr Emerg Care |
2004 |
Biederman J, Swanson JM, ... |
Efficacy and safety of modafinil film-coated tablets in children and a... |
Pediatrics |
2005 |
Cone EJ |
Ephemeral profiles of prescription drug and formulation tampering: Evo... |
Drug Alcohol Depend |
2006 |
Rasmussen N |
Making the first anti-depressant: amphetamine in American medicine, 19... |
J Hist Med Allied Sc... |
2006 |
Tallarida RJ |
An overview of drug combination analysis with isobolograms |
J Pharmacol Exp Ther |
2006 |
Bryner JK, Wang UK, Hui J... |
Dextromethorphan abuse in adolescence: an increasing trend: 1999-2004 |
Arch Pediatr Adolesc... |
2006 |
Addy P |
Facilitating transpersonal experiences with dextromethorphan: potentia... |
Journal of Transpers... |
2007 |
Ashton CH, Moore PB, Sum... |
Regulation of synthetic cannabinoids |
Lancet |
2009 |
Tadini KA, Campos PM |
In vivo skin effects of a dimethylaminoethanol (DMAE) based formulatio... |
Pharmazie |
2009 |
O'Connor EC, Mead AN |
Tramadol acts as a weak reinforcer in the rat self-administration mode... |
Pharmacol Biochem Be... |
2010 |
Krupitsky E, Nunes EV, Li... |
Injectable extended-release naltrexone for opioid dependence: a double... |
Lancet |
2011 |
Uchiyama N, Kikura-Hanaji... |
Identification of a Novel Cannabimimetic Phenylacetylindole, Cannabipi... |
Chem Pharm Bull (Tok... |
2011 |
Sumnall HR, Evans-Brown M... |
Social, policy, and public health perspectives on new psychoactive sub... |
Drug Test Anal |
2011 |
Goli V, Webster LR, Lamso... |
Effects of concurrent intravenous morphine sulfate and naltrexone hydr... |
Harm Reduct J |
2012 |
Zuba D, Seku?a K |
Analytical characterization of three hallucinogenic N-(2-methoxy)benzy... |
Drug Test Anal |
2012 |
Zuba D, Sekuła K, Bu... |
25C-NBOMe--new potent hallucinogenic substance identified on the drug ... |
Forensic Sci Int |
2013 |
Boyle KL, Rosenbaum CD |
Oxymorphone insufflation associated with acute sensorineural hearing l... |
J Med Toxicol |
2013 |
Liput DJ, Hammell DC, Sti... |
Transdermal delivery of cannabidiol attenuates binge alcohol-induced n... |
Pharmacol Biochem Be... |
2013 |
Seely KA, Patton AL, Mora... |
Forensic investigation of K2, Spice, and bath salt commercial preparat... |
Forensic Sci Int |
2013 |
Schoenfuss HL, Furlong ET... |
Complex mixtures, complex responses: Assessing pharmaceutical mixtures... |
Environ Toxicol Chem |
2015 |
Dierksen J, Gonsoulin M, ... |
Poor Man's Methadone: A Case Report of Loperamide Toxicity |
Am J Forensic Med Pa... |
2015 |
Katselou M, Papoutsis I, ... |
Old opioids, new concerns: the case of acetylfentanyl |
Forensic Toxicol |
2016 |
Csete J, Kamarulzaman A, ... |
Public health and international drug policy |
Lancet |
2016 |
Lee JD, Friedmann PD, Kin... |
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Just... |
N Engl J Med |
2016 |
Harned M, Sloan P |
Safety concerns with long-term opioid use |
Expert Opin Drug Saf |
2016 |
Kimergĺrd A, Deluca P, Hi... |
How Resistant to Tampering are Codeine Containing Analgesics on the Ma... |
Pain Ther |
2016 |
Trabsa A, Monteagudo E, M... |
What are sweet dreams made of? Analysis of psychoactive substances int... |
European Psychiatry |
2017 |
Aldridge J, Stevens A, Ba... |
Will growth in cryptomarket drug buying increase the harms of illicit ... |
Addiction |
2017 |
Iwersen-Bergmann S, Lehma... |
Mass poisoning with NPS: 2C-E and Bromo-DragonFly |
Int J Legal Med |
2018 |